奥浦迈: 奥浦迈：关于2025年半年度业绩预告的自愿性披露公告

Group 1 - The company expects a significant increase in its financial performance for the first half of 2025, with an estimated revenue increase of approximately 33.39 million yuan, representing a year-on-year growth of about 23.25% [1] - The net profit attributable to the parent company is projected to increase by approximately 12.86 million yuan, reflecting a year-on-year growth of about 53.28% [1] - The net profit after deducting non-recurring gains and losses is expected to rise by approximately 73.46% compared to the same period last year [1] Group 2 - The main driver of revenue growth is the product business segment, which has shown robust performance, with revenue growth exceeding 25% year-on-year for the first half of 2025 [2] - In the second quarter of 2025, the product business segment's growth accelerated further, with a year-on-year increase of over 50%, highlighting the strong competitiveness of product sales [2] - This growth is attributed to the company's continuous research and development innovations and market expansion in the cell culture media product field, leading to widespread recognition and application in both domestic and international markets [2]